130 related articles for article (PubMed ID: 37301605)
1. Human indoleamine-2,3-dioxygenase 2 cofactor lability and low substrate affinity explained by homology modeling, molecular dynamics and molecular docking.
Mirgaux M; Leherte L; Wouters J
J Biomol Struct Dyn; 2024 Jun; 42(9):4475-4488. PubMed ID: 37301605
[TBL] [Abstract][Full Text] [Related]
2. Heme-binding-mediated negative regulation of the tryptophan metabolic enzyme indoleamine 2,3-dioxygenase 1 (IDO1) by IDO2.
Lee YK; Lee HB; Shin DM; Kang MJ; Yi EC; Noh S; Lee J; Lee C; Min CK; Choi EY
Exp Mol Med; 2014 Nov; 46(11):e121. PubMed ID: 25394548
[TBL] [Abstract][Full Text] [Related]
3. Exploring a repurposed candidate with dual hIDO1/hTDO2 inhibitory potential for anticancer efficacy identified through pharmacophore-based virtual screening and in vitro evaluation.
Aboomar NM; Essam O; Hassan A; Bassiouny AR; Arafa RK
Sci Rep; 2024 Apr; 14(1):9386. PubMed ID: 38653790
[TBL] [Abstract][Full Text] [Related]
4. Structural Basis of Selective Human Indoleamine-2,3-dioxygenase 1 (hIDO1) Inhibition.
Kassab SE; Mowafy S
ChemMedChem; 2021 Oct; 16(20):3149-3164. PubMed ID: 34174026
[TBL] [Abstract][Full Text] [Related]
5. Inhibition Mechanisms of Human Indoleamine 2,3 Dioxygenase 1.
Lewis-Ballester A; Karkashon S; Batabyal D; Poulos TL; Yeh SR
J Am Chem Soc; 2018 Jul; 140(27):8518-8525. PubMed ID: 29897749
[TBL] [Abstract][Full Text] [Related]
6. Establishment of a human indoleamine 2, 3-dioxygenase 2 (hIDO2) bioassay system and discovery of tryptanthrin derivatives as potent hIDO2 inhibitors.
Li J; Li Y; Yang D; Hu N; Guo Z; Kuang C; Yang Q
Eur J Med Chem; 2016 Nov; 123():171-179. PubMed ID: 27475108
[TBL] [Abstract][Full Text] [Related]
7. Structural Basis of Inhibitor Selectivity in Human Indoleamine 2,3-Dioxygenase 1 and Tryptophan Dioxygenase.
Pham KN; Lewis-Ballester A; Yeh SR
J Am Chem Soc; 2019 Nov; 141(47):18771-18779. PubMed ID: 31682426
[TBL] [Abstract][Full Text] [Related]
8. Catalytic activity of human indoleamine 2,3-dioxygenase (hIDO1) at low oxygen.
Kolawole AO; Hixon BP; Dameron LS; Chrisman IM; Smirnov VV
Arch Biochem Biophys; 2015 Mar; 570():47-57. PubMed ID: 25712221
[TBL] [Abstract][Full Text] [Related]
9. Substrate binding in human indoleamine 2,3-dioxygenase 1: A spectroscopic analysis.
Nienhaus K; Nickel E; Nienhaus GU
Biochim Biophys Acta Proteins Proteom; 2017 Apr; 1865(4):453-463. PubMed ID: 28189796
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Molecular Modeling Studies of N'-Hydroxyindazolecarboximidamides as Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors.
Lee DH; Lee JY; Jeong J; Kim M; Lee KW; Jang E; Ahn S; Lee CH; Hwang JY
Molecules; 2017 Nov; 22(11):. PubMed ID: 29120388
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, biological evaluation of urea substituted 1,2,5-oxadiazole-3-carboximidamides as novel indoleamine 2,3-dioxygenase-1 (IDO1) inhibitors.
Ye K; Wang K; Wang T; Tang H; Wang L; Zhang W; Jiang S; Zhang X; Zhang K
Eur J Med Chem; 2023 Mar; 250():115217. PubMed ID: 36842272
[TBL] [Abstract][Full Text] [Related]
12. Computational study on new natural compound inhibitors of indoleamine 2,3-dioxygenase 1.
Jiang S; Li H; Piao L; Jin Z; Liu J; Chen S; Liu LL; Shao Y; Zhong S; Wu B; Li W; Ren J; Zhang Y; Wang H; Jin R
Aging (Albany NY); 2020 Jun; 12(12):11349-11363. PubMed ID: 32568737
[TBL] [Abstract][Full Text] [Related]
13. Substrate Oxidation by Indoleamine 2,3-Dioxygenase: EVIDENCE FOR A COMMON REACTION MECHANISM.
Booth ES; Basran J; Lee M; Handa S; Raven EL
J Biol Chem; 2015 Dec; 290(52):30924-30. PubMed ID: 26511316
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and biological evaluation of 1,2,5-oxadiazole-3-carboximidamide derivatives as novel indoleamine-2,3-dioxygenase 1 inhibitors.
Song X; Sun P; Wang J; Guo W; Wang Y; Meng LH; Liu H
Eur J Med Chem; 2020 Mar; 189():112059. PubMed ID: 31981851
[TBL] [Abstract][Full Text] [Related]
15. Temporary Intermediates of L-Trp Along the Reaction Pathway of Human Indoleamine 2,3-Dioxygenase 1 and Identification of an Exo Site.
Mirgaux M; Leherte L; Wouters J
Int J Tryptophan Res; 2021; 14():11786469211052964. PubMed ID: 34949925
[TBL] [Abstract][Full Text] [Related]
16. Molecular docking and dynamic simulation studies evidenced plausible immunotherapeutic anticancer property by Withaferin A targeting indoleamine 2,3-dioxygenase.
Reddy SV; Reddy KT; Kumari VV; Basha SH
J Biomol Struct Dyn; 2015; 33(12):2695-709. PubMed ID: 25671592
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 5-(N-hydroxycarbamimidoyl) benzofuran derivatives as novel indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
Jung J; Yoon H; Sohn TI; Jang K; Yoo Y; Jeong I; Shin JE; Lee JH; Ann J; Lee J
Bioorg Med Chem Lett; 2021 May; 40():127963. PubMed ID: 33741464
[TBL] [Abstract][Full Text] [Related]
18. Substrate and cofactor requirements of indoleamine 2,3-dioxygenase in interferon-gamma-treated cells: utilization of oxygen rather than superoxide.
Werner ER; Werner-Felmayer G
Curr Drug Metab; 2007 Apr; 8(3):201-3. PubMed ID: 17430107
[TBL] [Abstract][Full Text] [Related]
19. Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1.
Pantouris G; Serys M; Yuasa HJ; Ball HJ; Mowat CG
Amino Acids; 2014 Sep; 46(9):2155-63. PubMed ID: 24875753
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into substrate and inhibitor binding sites in human indoleamine 2,3-dioxygenase 1.
Lewis-Ballester A; Pham KN; Batabyal D; Karkashon S; Bonanno JB; Poulos TL; Yeh SR
Nat Commun; 2017 Nov; 8(1):1693. PubMed ID: 29167421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
